Our results suggest that adequate classification of the major and clinically relevant molecular subtypes of breast cancer can be robustly achieved with quantitative measurements of three key genes.
Journal of the National Cancer Institute
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. bhaibeka [at] jimmy.harvard.edu
J Natl Cancer Inst. 2012 Feb;104(4):311-25
© Galenicom 1999-2013